What do systematic reviews say?

GnRH‐a + tibolone vs GnRH‐a ± placebo

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 110 participants
  Low

Intervention not reported

• Topical herbal therapies for treating osteoarthritis 2013 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 220 participants
  Moderate

Intervention not reported

The review found no eligible studies for this question.

• Lacosamide for neuropathic pain and fibromyalgia in adults 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Orthodontic treatment with appliances inducing stable, permanent orthodontic tooth movement (splints worn 8 to 12 weeks and surgical interventions excluded) vs Control: no treatment, placebo, or reassurance

The review found no eligible studies for this question.

• Orthodontics for treating temporomandibular joint (TMJ) disorders 2010 · Cochrane All outcomes

  At least 6 months after the intervention
  no estimate extracted
  0 studies
  No studies found

Any antifungal intervention for the treatment of oral candidiasis vs Placebo, no treatment, or another active antifungal intervention

The review found no eligible studies for this question.

• Interventions for treating oral candidiasis for patients with cancer receiving treatment 2010 · Cochrane All outcomes
  None of the studies reported: relief of pain, relief of dysphagia, incidence of systemic infection, amount of analgesia, days stay in hospital, cost of oral care, patient quality of life.
  0 studies
  No studies found

Prophylactic aciclovir (oral or intravenous) vs placebo

The review found no eligible studies for this question.

• Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer 2009 · Cochrane All outcomes
  None of the prophylactic aciclovir versus placebo trials reported on patient quality of life. For prevention or treatment, no trials reported on duration of hospital stay, amount of analgesia or patient quality of life.
  0 studies
  No studies found

Aciclovir (oral or intravenous) for treatment vs placebo

The review found no eligible studies for this question.

• Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer 2009 · Cochrane All outcomes
  For the treatment comparison (aciclovir versus placebo), no data were available for recurrence of lesions, amount of analgesia, days of stay in hospital, cost of oral care or patient quality of life.
  0 studies
  No studies found

Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole, itraconazole) vs placebo or no treatment

The review found no eligible studies for this question.

• Interventions for preventing oral candidiasis for patients with cancer receiving treatment 2007 · Cochrane All outcomes
  No trial reported this planned secondary outcome for any comparison in this review
  Studies not reported
  No studies found

Iridotomy vs no iridotomy

The review found no eligible studies for this question.

• Iridotomy to slow progression of visual field loss in angle‐closure glaucoma 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Web‐based disease monitoring vs self‐screening

• Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 102 participants
  Very low

Telephone‐based disease monitoring vs face‐to‐face monitoring

• Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 123 participants
  Very low

Web‐based disease monitoring vs usual care

• Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 1099 participants
  Moderate

Web‐based disease monitoring vs sham monitoring

• Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 447 participants
  Very low

Laser trabeculoplasty vs medication

Laser trabeculoplasty showed no clear difference in quality of life measures compared with medication (moderate certainty).

• Laser trabeculoplasty for open‐angle glaucoma and ocular hypertension 2022 · Cochrane Headline outcomes only
  MD 0.28
  Studies not reported
  Moderate

Yoga vs no exercise

• Yoga for chronic non‐specific low back pain 2022 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 686 participants
  Moderate

Yoga vs exercise

• Yoga for chronic non‐specific low back pain 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 237 participants
  Very low

Yoga vs sham yoga

The review found no eligible studies for this question.

• Yoga for chronic non‐specific low back pain 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Phacoemulsification vs phacoemulsification plus viscogonioplasty

The review found no eligible studies for this question.

• Lens extraction for chronic angle‐closure glaucoma 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Phacoemulsification vs phacoemulsification plus goniosynechialysis

The review found no eligible studies for this question.

• Lens extraction for chronic angle‐closure glaucoma 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Laser peripheral iridoplasty for chronic angle closure 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found